StonvexLoading…
StonvexStonvexStonvexCore line items from OI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.54B | $6.43B | $4.93B | $3.27B |
Operating Income | $-53.00M | $-49.00M | $83.00M | $26.00M |
Net Income | $-73.00M | $-129.00M | $9.00M | $-20.00M |
EPS (Diluted) | $-0.48 | $-0.84 | $0.06 | $-0.13 |
Total Assets | $8.95B | $9.24B | $9.26B | $9.18B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $317.00M | $759.00M | $556.00M | $487.00M |
Free Cash Flow OCF − CapEx | $-436.00M | $168.00M | $-141.00M | $-255.00M |
Shares Outstanding | 152.68M | 153.55M | 155.41M | 153.85M |